Norden Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,082
Closed -$314K 663
2025
Q4
$314K Sell
5,082
-705
-12% -$43.2K 0.03% 451
2025
Q3
$361K Sell
5,787
-2,372
-29% -$165K 0.04% 426
2025
Q2
$651K Sell
8,159
-1,096
-12% -$91.7K 0.07% 276
2025
Q1
$796K Sell
9,255
-5,210
-36% -$427K 0.09% 214
2024
Q4
$1.13M Buy
14,465
+700
+5% +$54.3K 0.13% 165
2024
Q3
$992K Buy
13,765
+1,330
+11% +$94.2K 0.12% 197
2024
Q2
$856K Buy
12,435
+2,559
+26% +$173K 0.17% 131
2024
Q1
$717K Buy
9,876
+2,852
+41% +$191K 0.15% 162
2023
Q4
$430K Buy
7,024
+3,061
+77% +$182K 0.07% 155
2023
Q3
$227K Buy
+3,963
New +$240K 0.07% 221

Other funds holding PBH

Norden Group's PBH Position: Q1 2026 in Review

Norden Group sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 5,082 shares — an estimated $314K sold.

Norden Group first reported a position in PBH in Q3 2023 and held it in 10 quarters. The position peaked at $1.13M in Q4 2024. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Norden Group reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Norden Group sold 5,082 Prestige Consumer Healthcare shares in Q1 2026, an estimated $314K.
  • Norden Group first reported a position in Prestige Consumer Healthcare in Q3 2023 and held it in 10 quarters.
  • Norden Group's Prestige Consumer Healthcare position peaked at $1.13M in Q4 2024.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.